Experimental Researches of Cutaneous Melanoma Immunotherapy by Antitumor Cell-Whole GM-CSF-Producing Vaccines

TL;DR

This study investigates the effectiveness of a combined immunotherapy approach using GM-CSF-producing vaccines in melanoma, showing significant improvements in preventing tumor development and reducing metastasis in experimental models.

Contribution

It introduces a novel combined therapy strategy integrating vaccines with surgery, demonstrating enhanced antitumor and antimetastatic effects in melanoma models.

Findings

Preventive vaccination reduces tumor incidence by 70%.

Combination therapy increases antimetastatic activity by 43%.

Combined therapy leads to more effective antitumor response.

Abstract

Various approaches to increase efficiency of antitumor therapy by a combination of vaccinotherapy, chemotherapy and surgical excision of primary tumor nodes, and also the comparative analyses of therapeutic and preventive application of antitumoral vaccines were carried out in melanoma experimental model. It was postulated that preventive vaccination is able to prevent tumor incidence by 70 %. The combination of vaccinotherapy and surgical treatment of melanoma increases antimetastatic activity of vaccination by 43 %. We conclude the combined therapy would lead to more effective antitumor response.